Patents by Inventor Ole Magne Homestad

Ole Magne Homestad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6974882
    Abstract: A process for the preparation of iodixanol by dimerization of 5-acetamido-N,N?-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-isophthalamide (“Compound A”) in which, after the dimerization step, unreacted Compound A is precipitated from the reaction mixture and recovered for re-use. The process substantially increases the net yield of iodixanol and simplifies its purification.
    Type: Grant
    Filed: August 6, 2001
    Date of Patent: December 13, 2005
    Assignee: Amersham Health AS
    Inventor: Ole Magne Homestad
  • Publication number: 20020010368
    Abstract: A process for the preparation of iodixanol by dimerisation of 5-acetamido-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-isophthalamide (“Compound A”) in which, after the dimerisation step, unreacted Compound A is precipitated from the reaction mixture and recovered for re-use. The process substantially increases the net yield of iodixanol and simplifies its purification.
    Type: Application
    Filed: August 6, 2001
    Publication date: January 24, 2002
    Inventor: Ole Magne Homestad
  • Patent number: 6274762
    Abstract: The invention provides an improved process for the preparation of a compound containing a 2,4,6-triiodinated benzene ring, said process comprising reacting a 2,4,6-unsubstituted 5-amino-benzoic acid or derivative there of with an iodine halide iodinating agent in an aqueous reaction medium, characterised in that the iodinating agent is added to an aqueous medium containing the 5-amino-benzoic acid or derivative at two different temperature ranges: (A) one or more primary portions of the agent are added at a temperature in the range 40 to 70° C. and then one or more secondary portions of the agent are added at a temperature in the range 75 to 95° C. or (B) one or more primary portions of the agent are added at a temperature in the range 75 to 95° C. and then one or more secondary portions of the agent are added at a temperature of 60 to 70° C.
    Type: Grant
    Filed: November 12, 1999
    Date of Patent: August 14, 2001
    Assignee: Nycomed Imaging AS
    Inventors: Dick Malthe-Sorenssen, Ole Magne Homestad, Britt Sterud